Funding supports trial of TT-P34 as potential treatment
Teitur Trophics has raised €28 million (about $29.7 million) to advance its lead candidate, TT-P34, into a Phase 1b…
Articles by Andrea Lobo
Parkinson’s, specific cancers share genetic risk factors: Study
Researchers have found a genetic association between Parkinson’s disease and melanoma, a type of skin cancer, and prostate cancer. Data…
Inbrija, inhaled levodopa for patients’ off episodes, arrives in Spain
Inbrija (levodopa inhalation powder), an approved therapy for off episodes in Parkinson’s patients on certain standard levodopa-based treatments, is now…
Older age at DBS surgery raises risk of death over subsequent years
Older Parkinson’s patients undergoing deep brain stimulation (DBS), those in their 60s and 70s at the time of…
How Parkinson’s May Affect Sexes Differently Examined in US Study
Men with mild-to-moderate Parkinson’s disease may experience greater effects of the disease on certain aspects of their life than…
Evening Primrose Oil Found to Ease Inflammation in Parkinsonism Rats
Treatment with evening primrose oil or EPO — made from the seeds of the flowering plant — was found to…
Fatty Liver Disease Not Linked to Increased Risk of Parkinson’s
Fatty liver disease may not be among the risk factors for Parkinson’s in either men or women, according to…
Online Educational Series for Healthcare Professionals Begins
The Parkinson’s Foundation has launched a new education series for healthcare professionals to improve the treatment and health outcomes…
Virtual Reality System May Help Diagnose Parkinson’s
DiagnaMed Holdings will develop a virtual reality and artificial intelligence tool (VR/AI Neuro) for the diagnosis of neurodegenerative diseases,…
Suppressing Enzyme Synuclein Nitrase Could Lead to New Therapies
Nitrase Therapeutics showed suppressing the activity of an enzyme called synuclein nitrase reduces toxic clumps of the alpha-synuclein protein…